feature_name,feature_value,shap_value,absolute_shap_value,predicted_probability,drug_name,pt_name,case_row_index
sex_ratio,0.25,3.3086848,3.3086848,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
soc_match,1.0,0.9454969,0.9454969,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
drug_concomitant_avg,5.78125,-0.6947775,0.6947775,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
drug_duration_mode_360_d+,0.0,-0.1259263,0.1259263,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
outc_cod_mode__missing,0.0,0.0979045,0.0979045,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
drug_duration_mode__missing,0.0,0.07723052,0.07723052,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
age_group_mode__missing,0.0,0.07461135,0.07461135,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
age_group_mode_18-30,1.0,0.07445645,0.07445645,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
soc_n_Nervous_system_disorders,1.0,0.06562259,0.06562259,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
weight_group_mode_60-75,0.0,-0.063349284,0.063349284,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
outc_cod_mode_OT,0.0,-0.05305327,0.05305327,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
weight_group_mode__missing,0.0,0.049503766,0.049503766,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
outc_cod_mode_HO,1.0,0.029951632,0.029951632,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
soc_n_General_disorders_and_administration_site_conditions,0.0,-0.029325852,0.029325852,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
soc_n_Psychiatric_disorders,0.0,-0.027557073,0.027557073,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
outc_cod_mode_DS,0.0,0.0229546,0.0229546,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
drug_duration_mode_0-30_d,1.0,-0.021920312,0.021920312,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
soc_n_Investigations,0.0,0.017931381,0.017931381,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
weight_group_mode_45-60,1.0,0.014762185,0.014762185,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
soc_n_Gastrointestinal_disorders,0.0,-0.012784368,0.012784368,0.9778066,SARAFEM,SEROTONIN SYNDROME,1845233
